Köhler Stephan, Unger Theresa, Hoffmann Sabine, Mackert Arthur, Ross Barbara, Fydrich Thomas
Kliniken im Theodor-Wenzel-Werk, Department of Psychiatry and Psychotherapy, Berlin.
Humboldt-University, Department of Psychology, Berlin.
Compr Psychiatry. 2015 Apr;58:50-6. doi: 10.1016/j.comppsych.2014.12.020. Epub 2015 Jan 13.
Dysfunctional cognitions can contribute to depression and its maintenance. They may be related to a higher relapse rate and a longer duration of the depressive episode. The relevance of dysfunctional cognitions for acute inpatient treatment of unipolar depression is examined in this study and its variability by cognitive behavioural therapy (CBT).
222 patients suffering from Major Depressive Disorder (MDD) were evaluated during their inpatient treatment by assessing admission and discharge depression scores and their relationship to dysfunctional cognitions, using the Dysfunctional Attitude Scale (DAS). The relationship between dysfunctional cognitions and treatment outcome was examined. Primary outcome measures were the Hamilton-Rating-Scale (HRSD) and the Beck Depression Inventory (BDI).
Higher age, depression severity at admission, comorbid personality disorders and recurrent depressive disorders are related with higher DAS-scores at admission. DAS-Scores declined during treatment but to a lower extend than depressive symptom scales (effect size dDAS-G t1-t2 = .31; dHRSD t1-t2 = 2.88; dBDI t1-t2 = 1.38). Higher DAS-scores at admission correlated negatively with the improvement of depressive symptoms during treatment (HRSD: r = -.62; p < .01; BDI: r = -.54; p < .01) and remission rates (HRSD: r = -.65; p < .01; BDI: r = -.48; p < .01). CBT did not additionally reduce DAS-scores compared to pharmacotherapy only.
Dysfunctional cognitions are relatively stable compared to other depressive symptoms and are associated with poorer treatment outcome even in combined treatment of antidepressant medication and CBT during inpatient treatment. Changes of dysfunctional cognitions seem to be a long-term treatment goal, especially because of their association with comorbid personality disorders and recurrent depressive disorders.
功能失调性认知可能导致抑郁及其持续存在。它们可能与更高的复发率和更长的抑郁发作持续时间有关。本研究探讨了功能失调性认知在单相抑郁症急性住院治疗中的相关性及其通过认知行为疗法(CBT)产生的变异性。
对222名患有重度抑郁症(MDD)的患者在住院治疗期间进行评估,通过使用功能失调性态度量表(DAS)评估入院和出院时的抑郁评分及其与功能失调性认知的关系。研究了功能失调性认知与治疗结果之间的关系。主要结局指标为汉密尔顿抑郁量表(HRSD)和贝克抑郁量表(BDI)。
年龄较大、入院时抑郁严重程度较高、共病的人格障碍和复发性抑郁症与入院时较高的DAS评分相关。治疗期间DAS评分下降,但下降幅度低于抑郁症状量表(效应大小dDAS-G t1-t2 = 0.31;dHRSD t1-t2 = 2.88;dBDI t1-t2 = 1.38)。入院时较高的DAS评分与治疗期间抑郁症状的改善呈负相关(HRSD:r = -0.62;p < 0.01;BDI:r = -0.54;p < 0.01)以及缓解率(HRSD:r = -0.65;p < 0.01;BDI:r = -0.48;p < 0.01)。与仅药物治疗相比,CBT并未额外降低DAS评分。
与其他抑郁症状相比,功能失调性认知相对稳定,即使在住院治疗期间联合使用抗抑郁药物和CBT,其也与较差的治疗结果相关。功能失调性认知的改变似乎是一个长期的治疗目标,特别是考虑到它们与共病的人格障碍和复发性抑郁症的关联。